According to our (Global Info Research) latest study, the global Virtual Screening Technology Service market size was valued at US$ 501 million in 2025 and is forecast to a readjusted size of US$ 1077 million by 2032 with a CAGR of 11.6% during review period.
Virtual Screening Technology Service refer to computation-driven technical services used in early-stage molecular discovery, especially in drug discovery, where service providers apply computational chemistry, structural biology, molecular docking, pharmacophore modeling, shape- and fingerprint-based similarity search, QSAR/QSPR, molecular dynamics, free-energy calculations, machine learning, deep learning, generative AI, and high-performance computing to evaluate, rank, and prioritize compounds from real compound collections, purchasable libraries, make-on-demand virtual chemical spaces, or customer-provided molecular datasets.
Based on our research, Virtual Screening Technology Service are evolving from a supporting function within traditional CADD into a more independent, platform-enabled service module in early-stage discovery. The market should not be broadly equated with all CADD software, all AI drug discovery, or all discovery CRO revenue. A more reliable narrow scope focuses on commercially delivered computational screening, compound prioritization, ultra-large chemical-space search, and AI-enabled hit finding. Traditional docking, pharmacophore modeling, shape similarity, and fingerprint-based screening remain the foundation of the field, while AI/ML, active learning, generative molecular design, free-energy rescoring, and automated experimental validation are increasingly integrated into a closed discovery loop. The core value of this service is not to replace experimental screening entirely, but to reduce the number of compounds that need to be synthesized or tested, improve hit quality, and provide more actionable starting points for hit-to-lead and lead optimization.
From the supply side, global providers fall into four major groups. Specialist software and platform vendors such as Schrödinger, Cadence/OpenEye, Cresset, BioSolveIT and Pharmacelera compete on algorithms, cloud workflows and large-scale screening infrastructure. CRO and discovery-service companies such as WuXi AppTec, Pharmaron, Charles River, Sygnature Discovery, Evotec, Selvita, Aurigene and Jubilant Biosys embed virtual screening into broader medicinal chemistry, biology and hit-identification projects. AI drug discovery companies such as XtalPi, Insilico Medicine, DP Technology, StoneWise, HITS, Standigm, Syntekabio and Receptor.AI compete through AI models, proprietary data, generative design and closed-loop discovery capabilities. Compound-library-enabled players such as Enamine, Chemspace, eMolecules, ChemDiv and TargetMol add value by linking virtual libraries to procurement or synthesis. The broad vendor pool is therefore much larger than the core formal list because many related companies sell software, datasets, compounds or compute infrastructure rather than clearly attributable virtual screening services.
Demand is led by pharmaceutical companies, biotech firms, academic translational groups, agrochemical companies, materials discovery teams and AI-enabled discovery platforms. Growth is supported by three structural drivers: the rising need to explore novel and difficult targets, the rapid expansion of synthesizable chemical spaces that cannot be covered economically by wet screening alone, and the availability of AI models, cloud HPC and automated synthesis/testing systems that lower the barrier to large-scale computational screening. In 2025–2026, the fastest growth is expected in ultra-large library screening, AI rescoring, generative hit discovery, CADD-to-biology closed loops, and the commercialization of Chinese and Korean AI discovery platforms. At the same time, simple docking-only services face pricing pressure from open-source tools, standardized workflows and increasing internal capabilities at large pharmaceutical companies.
This report is a detailed and comprehensive analysis for global Virtual Screening Technology Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Virtual Screening Technology Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Virtual Screening Technology Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Virtual Screening Technology Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Virtual Screening Technology Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Virtual Screening Technology Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Virtual Screening Technology Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Schrödinger, Cadence, WuXi AppTec, XtalPi, Insilico Medicine, Sygnature Discovery, Charles River, Pharmaron, Evotec, Cresset Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Virtual Screening Technology Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Structure-Based Virtual Screening
Ligand-Based Virtual Screening
Others
Market segment by Service Model
One-time Project Services
Long-term Subscription Services
Market segment by Technical Principles
Structure-Based Virtual Screening (SBVS)
Ligand-Based Virtual Screening (LBVS)
Market segment by Application
Pharmaceutical Industry
Biotechnology Industry
Academic Research Institutions
Others
Market segment by players, this report covers
Schrödinger
Cadence
WuXi AppTec
XtalPi
Insilico Medicine
Sygnature Discovery
Charles River
Pharmaron
Evotec
Cresset Group
BioSoIvelT
Enamine
Aurigene Services
Selvita
HITS
Standigm
Syntekabio
Pharmacelera
Receptor.AI
Chemspace
Jubilant Biosys
Aragen
Domainex
NUVISAN
Concept Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Virtual Screening Technology Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Virtual Screening Technology Service, with revenue, gross margin, and global market share of Virtual Screening Technology Service from 2021 to 2026.
Chapter 3, the Virtual Screening Technology Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Virtual Screening Technology Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Virtual Screening Technology Service.
Chapter 13, to describe Virtual Screening Technology Service research findings and conclusion.
Summary:
Get latest Market Research Reports on Virtual Screening Technology Service. Industry analysis & Market Report on Virtual Screening Technology Service is a syndicated market report, published as Global Virtual Screening Technology Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Virtual Screening Technology Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.